These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 24424134

  • 1. Diphenylpyridylethanamine (DPPE)-based aminoheterocycles as cholesteryl ester transfer protein inhibitors.
    Wang Y, Yang W, Finlay HJ, Harikrishnan LS, Jiang J, Kamau MG, Van Kirk K, Nirschl DS, Taylor DS, Chen AY, Yin X, Sleph PG, Yang RZ, Huang CS, Adam LP, Lawrence RM, Wexler RR, Salvati ME.
    Bioorg Med Chem Lett; 2014 Feb 01; 24(3):860-4. PubMed ID: 24424134
    [Abstract] [Full Text] [Related]

  • 2. Diphenylpyridylethanamine (DPPE) derivatives as cholesteryl ester transfer protein (CETP) inhibitors.
    Harikrishnan LS, Finlay HJ, Qiao JX, Kamau MG, Jiang J, Wang TC, Li J, Cooper CB, Poss MA, Adam LP, Taylor DS, Chen AY, Yin X, Sleph PG, Yang RZ, Sitkoff DF, Galella MA, Nirschl DS, Van Kirk K, Miller AV, Huang CS, Chang M, Chen XQ, Salvati ME, Wexler RR, Lawrence RM.
    J Med Chem; 2012 Jul 12; 55(13):6162-75. PubMed ID: 22650305
    [Abstract] [Full Text] [Related]

  • 3. Identification of a potent and metabolically stable series of fluorinated diphenylpyridylethanamine-based cholesteryl ester transfer protein inhibitors.
    Miller MM, Liu Y, Jiang J, Johnson JA, Kamau M, Nirschl DS, Wang Y, Harikrishnan L, Taylor DS, Chen AY, Yin X, Seethala R, Peterson TL, Zvyaga T, Zhang J, Huang CS, Wexler RR, Poss MA, Lawrence RM, Adam LP, Salvati ME.
    Bioorg Med Chem Lett; 2012 Oct 15; 22(20):6503-8. PubMed ID: 22995620
    [Abstract] [Full Text] [Related]

  • 4. 2D and 3D QSAR models for identifying diphenylpyridylethanamine based inhibitors against cholesteryl ester transfer protein.
    Chen M, Yang X, Lai X, Gao Y.
    Bioorg Med Chem Lett; 2015 Oct 15; 25(20):4487-95. PubMed ID: 26346366
    [Abstract] [Full Text] [Related]

  • 5. Design of a novel class of biphenyl CETP inhibitors.
    Lu Z, Napolitano JB, Theberge A, Ali A, Hammond ML, Tan E, Tong X, Xu SS, Latham MJ, Peterson LB, Anderson MS, Eveland SS, Guo Q, Hyland SA, Milot DP, Chen Y, Sparrow CP, Wright SD, Sinclair PJ.
    Bioorg Med Chem Lett; 2010 Dec 15; 20(24):7469-72. PubMed ID: 21041082
    [Abstract] [Full Text] [Related]

  • 6. Facile entry to an efficient and practical enantioselective synthesis of a polycyclic cholesteryl ester transfer protein inhibitor.
    Han ZS, Xu Y, Fandrick DR, Rodriguez S, Li Z, Qu B, Gonnella NC, Sanyal S, Reeves JT, Ma S, Grinberg N, Haddad N, Krishnamurthy D, Song JJ, Yee NK, Pfrengle W, Ostermeier M, Schnaubelt J, Leuter Z, Steigmiller S, Däubler J, Stehle E, Neumann L, Trieselmann T, Tielmann P, Buba A, Hamm R, Koch G, Renner S, Dehli JR, Schmelcher F, Stange C, Mack J, Soyka R, Senanayake CH.
    Org Lett; 2014 Aug 15; 16(16):4142-5. PubMed ID: 25084526
    [Abstract] [Full Text] [Related]

  • 7. Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors.
    Eary CT, Jones ZS, Groneberg RD, Burgess LE, Mareska DA, Drew MD, Blake JF, Laird ER, Balachari D, O'Sullivan M, Allen A, Marsh V.
    Bioorg Med Chem Lett; 2007 May 01; 17(9):2608-13. PubMed ID: 17331716
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and discovery of 2,3-dihydro-3,8-diphenylbenzo[1,4]oxazines as a novel class of potent cholesteryl ester transfer protein inhibitors.
    Wang A, Prouty CP, Pelton PD, Yong M, Demarest KT, Murray WV, Kuo GH.
    Bioorg Med Chem Lett; 2010 Feb 15; 20(4):1432-5. PubMed ID: 20089400
    [Abstract] [Full Text] [Related]

  • 9. Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitors.
    Wu Z, Yang C, Graham TH, Verras A, Chabin RM, Xu S, Tong X, Xie D, Lassman ME, Bhatt UR, Garcia-Calvo MM, Shen Z, Chen Q, Bleasby K, Sinharoy R, Hale JJ, Tata JR, Pinto S, Colletti SL, Shen DM.
    Bioorg Med Chem Lett; 2012 Feb 15; 22(4):1727-30. PubMed ID: 22290078
    [Abstract] [Full Text] [Related]

  • 10. Design, Synthesis, and Biological Evaluation of N,N-Disubstituted-4-Arylthiazole-2-Methylamine Derivatives as Cholesteryl Ester Transfer Inhibitors.
    Wang X, Lin X, Xu X, Li W, Hao L, Liu C, Zhao D, Cheng M.
    Molecules; 2017 Nov 07; 22(11):. PubMed ID: 29112169
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of basic, heterocyclic ring systems as templates for use as potassium competitive acid blockers (pCABs).
    Panchal T, Bailey N, Bamford M, Demont E, Elliott R, Farre-Gutierrez I, Garton N, Hayhow T, Hutley G, Naylor A.
    Bioorg Med Chem Lett; 2009 Dec 01; 19(23):6813-7. PubMed ID: 19846298
    [Abstract] [Full Text] [Related]

  • 12. 2-Phenyl and 2-heterocyclic-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridines as inhibitors of TGF-β1 and activin A signalling.
    Ciayadi R, Potdar M, Walton KL, Harrison CA, Kelso GF, Harris SJ, Hearn MT.
    Bioorg Med Chem Lett; 2011 Sep 15; 21(18):5642-5. PubMed ID: 21783359
    [Abstract] [Full Text] [Related]

  • 13. 2D Quantitative structure-activity relationship studies on a series of cholesteryl ester transfer protein inhibitors.
    Castilho MS, Guido RV, Andricopulo AD.
    Bioorg Med Chem; 2007 Sep 15; 15(18):6242-52. PubMed ID: 17604633
    [Abstract] [Full Text] [Related]

  • 14. Discovery of hydroxyl 1,2-diphenylethanamine analogs as potent cholesterol ester transfer protein inhibitors.
    Jiang J, Finlay H, Johnson JA, Harikrishnan L, Kamau M, Qiao J, Wang T, Adam L, Taylor D, Yang R, Sleph P, Chen AYA, Yin X, Wexler R, Salvati ME.
    Bioorg Med Chem Lett; 2016 Jul 15; 26(14):3278-3281. PubMed ID: 27256912
    [Abstract] [Full Text] [Related]

  • 15. Isopropylidene substitution increases activity and selectivity of biphenylmethylene 4-pyridine type CYP17 inhibitors.
    Hu Q, Yin L, Jagusch C, Hille UE, Hartmann RW.
    J Med Chem; 2010 Jul 08; 53(13):5049-53. PubMed ID: 20550118
    [Abstract] [Full Text] [Related]

  • 16. Design and synthesis of potent inhibitors of cholesteryl ester transfer protein (CETP) exploiting a 1,2,3,4-tetrahydroquinoline platform.
    Rano TA, Sieber-McMaster E, Pelton PD, Yang M, Demarest KT, Kuo GH.
    Bioorg Med Chem Lett; 2009 May 01; 19(9):2456-60. PubMed ID: 19339179
    [Abstract] [Full Text] [Related]

  • 17. 2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: optimization via array synthesis.
    Harikrishnan LS, Kamau MG, Herpin TF, Morton GC, Liu Y, Cooper CB, Salvati ME, Qiao JX, Wang TC, Adam LP, Taylor DS, Chen AY, Yin X, Seethala R, Peterson TL, Nirschl DS, Miller AV, Weigelt CA, Appiah KK, O'Connell JC, Michael Lawrence R.
    Bioorg Med Chem Lett; 2008 Apr 15; 18(8):2640-4. PubMed ID: 18374566
    [Abstract] [Full Text] [Related]

  • 18. Design and synthesis of potent hydroxyethylamine (HEA) BACE-1 inhibitors carrying prime side 4,5,6,7-tetrahydrobenzazole and 4,5,6,7-tetrahydropyridinoazole templates.
    Sund C, Belda O, Borkakoti N, Lindberg J, Derbyshire D, Vrang L, Hamelink E, Åhgren C, Woestenenk E, Wikström K, Eneroth A, Lindström E, Kalayanov G.
    Bioorg Med Chem Lett; 2012 Nov 01; 22(21):6721-7. PubMed ID: 23010268
    [Abstract] [Full Text] [Related]

  • 19. Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration.
    Abu Khalaf R, Abu Sheikha G, Bustanji Y, Taha MO.
    Eur J Med Chem; 2010 Apr 01; 45(4):1598-617. PubMed ID: 20116902
    [Abstract] [Full Text] [Related]

  • 20. Biphenyl-substituted oxazolidinones as cholesteryl ester transfer protein inhibitors: modifications of the oxazolidinone ring leading to the discovery of anacetrapib.
    Smith CJ, Ali A, Hammond ML, Li H, Lu Z, Napolitano J, Taylor GE, Thompson CF, Anderson MS, Chen Y, Eveland SS, Guo Q, Hyland SA, Milot DP, Sparrow CP, Wright SD, Cumiskey AM, Latham M, Peterson LB, Rosa R, Pivnichny JV, Tong X, Xu SS, Sinclair PJ.
    J Med Chem; 2011 Jul 14; 54(13):4880-95. PubMed ID: 21682257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.